|
|
Volumn 23, Issue 7 SUPPL., 2000, Pages
|
|
Class effects and evidence-based medicine
|
|
Author keywords
Angiotensin converting enzyme inhibitor; Cardiovascular morbidity and mortality; Heart Outcomes Prevention Evaluation study; Lipophilicity; Pharmacodynamic; Pharmacokinetic
|
|
Indexed keywords
ANGIOTENSIN;
BENAZEPRIL;
CAPTOPRIL;
DIPEPTIDYL CARBOXYPEPTIDASE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ENALAPRIL;
FOSINOPRIL;
LISINOPRIL;
PERINDOPRIL;
PRODRUG;
QUINAPRIL;
RAMIPRIL;
SPIRAPRIL;
TRANDOLAPRIL;
ZINC;
ARTICLE;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG ELIMINATION;
DRUG HALF LIFE;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG POTENCY;
DRUG STRUCTURE;
EVIDENCE BASED MEDICINE;
HEART FAILURE;
HEART INFARCTION;
HUMAN;
HYPERTENSION;
LIPOPHILICITY;
NONHUMAN;
|
|
EID: 17744405364
PISSN: 01609289
EISSN: None
Source Type: Journal
DOI: 10.1002/clc.4960230705 Document Type: Article |
|
Times cited : (26)
|
|
References (26)
|
